Skip to main content

Bruker, Protein Discovery to Co-Market Imaging Mass-Spec Products

NEW YORK, May 30 (GenomeWeb News) - Bruker Daltonics and Protein Discovery will co-market MALDI molecular imaging mass spectrometry products for protein biomarker discovery, the companies said today.

 

Protein Discovery holds a license from Vanderbilt University to provide imaging mass spectrometry services to customers in the research, pharmaceutical and diagnostics industries. Bruker, meantime, markets the MALDI Molecular Imager for this technique for research use only with Professor Richard Caprioli at Vanderbilt.

 

Protein Discovery's imaging mass spectrometry service laboratory is currently outfitted with Bruker instrumentation.

 

MALDI molecular imaging mass spectrometry reads cell type-specific protein and peptide mass spectra directly from sliced tissues. The imaging resolution of the technique enables differential mass spectrometry analysis of adjacent tissue types within a single tissue slice, such as cancerous versus non-cancerous regions.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.